Sage Journals: Discover world-class research

Abstract

Stress and associated dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis is central to major depression etiology, as HPA axis hyperactivity and hypercortisolism are common occurrences in individuals with depression. Reelin, an extracellular matrix glycoprotein that plays numerous roles in brain development and function, is downregulated in several neuropsychiatric disorders. Reelin and its receptors are present throughout the HPA axis, and research has found that reelin levels are decreased in animal models of chronic stress in the hypothalamus. There may therefore be roles for reelin in regulating aspects of healthy HPA axis function and for reelin supplementation in restoring various facets of HPA axis function in chronic stress conditions, particularly those associated with HPA axis inhibition and stimulation. This review aims to summarize proposed roles for reelin in HPA axis activity, with a focus on the direct and indirect roles of reelin in restoring HPA axis homeostasis in chronic stress and depression. This review will explore possible interactions between reelin and the HPA axis in chronic stress conditions in order to expand our understanding of the mechanisms underlying the neurobiology of depression.

Keywords

reelin glucocorticoids oxytocin paraventricular nucleus hypothalamic-pituitary-adrenal axis endocrine system chronic stress depression

Introduction

In recent years, there has been a stronger focus on the role of the neuro-endocrine and neuro-immune systems in contributing to the development and progression of depression. The hypothalamic-pituitary-adrenal (HPA) axis regulates the stress response to modify physiological and behavioral reactions to environmental and internal challenges. Under healthy conditions, the stress response is a self-limiting process that is regulated by negative feedback loops in response to elevated levels of glucocorticoids (GCs).¹ However, under conditions of intense, frequent, or prolonged stress, negative feedback can be disrupted causing sustained elevations in circulating GCs.¹ Chronic elevation of GCs has been proposed to cause widespread effects on the brain and body, notably via immune activation, that contribute to the development of depressive symptoms.²

The Reeler mouse was first identified in 1951 following observations of physical and behavioral abnormalities that included tremors, ataxia, and impaired motor coordination.³ These characteristics are the results of an autosomal recessive mutation in the reln gene which encodes the reelin protein that was later identified in 1995.^3,4 In embryonic development, reelin is secreted by Cajal-Retzius cells in the marginal zone of the cortex and hippocampus and controls the migration of newborn neurons to ensure proper layering of neurons in the cortex, hippocampus, cerebellum, and spinal cord.^5–7 Accordingly, Reeler mice lack reelin and have aberrant lamination of layered structures of the brain, leading to the aforementioned abnormalities.⁴

Reelin serves a variety of functions in the adult brain, notably the regulation of synaptic plasticity, dendritogenesis, and neurotransmission.^8,9 Reelin binding induces clustering of very low-density lipoprotein receptor (VLDLR) and apolipoprotein E receptor 2 (ApoER2), and phosphorylation of the intracellular adaptor protein Disabled-1 (Dab1) by Src and Fyn, two Src family kinases.^10,11 Phosphorylation of Dab1 activates downstream signaling cascades through the mechanistic target of rapamycin complex 1 (mTORC1) that promote long-term potentiation (LTP) by driving the membrane insertion and retention of synapse-related proteins and protein complexes such as N-methyl-D-aspartate (NMDA) receptors and α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors.^12,13 Reelin binding to ApoER2 modulates synaptic plasticity pre-synaptically by triggering an influx of Ca²⁺ ions which enhances spontaneous neurotransmission without affecting evoked neurotransmission.¹⁴ Reelin facilitates dendritogenesis and synaptogenesis through N-cofilin-, Rap1-, and Glycogen synthase kinase 3 beta (GSK3β)-mediated modulation of cytoskeletal dynamics to influence the extension and arborization of dendritic processes and dendritic spine maturation.^10,15 In the subgranular zone of the dentate gyrus, reelin promotes the maturation of newborn neurons, as well as their integration into existing circuits.¹⁶

Hippocampal reelin and peripheral reelin levels are reduced in individuals with depression and in other neuropsychiatric disorders (eg schizophrenia, bipolar disorder, Alzheimer's disease, autism).^17–21 Decreases to reelin-immunoreactive (IR) cell populations and reelin mRNA have been shown in the hippocampus and hypothalamus in preclinical rodent models of chronic stress, and homozygous (reln−/−) and heterozygous (reln+/−) Reeler mice emulate symptoms of a range of neuropsychiatric conditions.^22–25 As depression and chronic stress are commonly associated with disrupted HPA axis function, and evidence suggests that reelin signaling may impact HPA axis activity, there is a possibility that alterations in reelin and reelin signaling pathways are implicated in dysregulated HPA axis function in the context of chronic stress and/or depression.

This narrative review provides a comprehensive overview of our present day understanding of reelin in the HPA axis, highlighting potential mechanisms through which reelin and the HPA axis interact in conditions of chronic stress. However, further research is necessary before a complete understanding can be developed of the numerous mechanisms through which reelin and the HPA axis interact. The goal of this review is to guide future research seeking to expand our current knowledge of reelin, the HPA axis, and the neurobiology of depression.

Neurobiological Progressions of Chronic Stress and Hypothalamic-Pituitary-Adrenal Axis Involvement

The HPA axis is a precisely regulated system that rapidly generates GCs in response to stress which promotes energy mobilization, suppresses immune responses, and modulates emotion, mood, cognition, and learning.^26–29 Parvocellular neurons in the hypothalamic paraventricular nucleus (PVN) release corticotropin-releasing hormone (CRH) through the hypophyseal portal system which directly innervates the anterior pituitary.³⁰ In response, corticotroph cells of the anterior pituitary gland enhance release of pro-opiomelanocortin, which is cleaved into adrenocorticotropic hormone (ACTH) and various byproducts and released into circulation.³¹ ACTH stimulates the secretion of GCs (primarily cortisol in humans and corticosterone (CORT) in rodents) from endocrine cells in the zona fasciculata of the adrenal cortex.³⁰ GCs diffuse across the cell membrane of target cells and bind to cytosolic glucocorticoid receptors (GR), triggering GR trafficking to the nucleus to affect gene transcription.³² Virtually all tissues of the body express GRs.³³ As mentioned above, under healthy conditions the HPA axis is tightly regulated through a GC-dependent negative feedback on the hypothalamus and anterior pituitary that dampens the production of both CRH and ACTH.¹ Under conditions of prolonged stress, however, chronic exposure to GCs results in blunted sensitivity of the HPA axis to inhibition by GCs.^1,34 This blunted sensitivity is partly the result of a downregulation of GRs that impairs homeostatic suppression of the HPA axis, resulting in prolonged elevation of circulating GCs.^35,36

Under healthy conditions, GCs act to suppress immune responses primarily through genomic mechanisms including through the repression of activator protein 1 and nuclear factor-κB, which reduces lymphocyte proliferation and activity and impedes the expression of cytokines, chemokines, and adhesion molecules by innate immune cells.³⁷ Similar to the HPA axis, immune cells become resistant to the inhibitory effects of GCs under conditions of chronic stress in part through stress-induced disruptions to GR signaling pathways, leading to increased production of pro-inflammatory cytokines.^38,39 Evidence suggests that in the brain, pro-inflammatory cytokines decrease monoamine signaling directly through the inhibition of vesicular monoamine transporter-dependent packaging into secretory vesicles.⁴⁰ Similarly, these cytokines may decrease signaling indirectly through the promotion of microglia-mediated production of reactive oxygen species and reactive nitrogen species.⁴⁰ Disruptions to monoamine synthesis and signaling induced by pro-inflammatory cytokines contributes to the mood disturbances observed in chronic stress and depression. Additionally, pro-inflammatory cytokines such as interleukin-6, tumor necrosis factor-α, and interferon-γ bias tryptophan/kynurenine synthesis towards kynurenine, decreasing serotonin synthesis and promoting the inhibition of the excitatory amino acid transporter, leading to excitotoxicity and neuron cell death at glutamatergic terminals.⁴¹ Pro-inflammatory cytokines also inhibit brain-derived neurotrophic factor (BDNF), a modulator of synaptic function, at glutamatergic terminals.^42,43 In the context of synaptic plasticity, GCs inhibit signaling through the mechanistic target of rapamycin (mTOR), a key component for the transcription of proteins necessary for glutamatergic synapse maturation and LTP.⁴⁴ As glutamate signaling is necessary for LTP, a reduction or loss of glutamate release, receptors, or clearance experienced in unhealthy or chronically stressed conditions can be detrimental to processes of learning and memory and can contribute to the cognitive symptoms characteristic of depression.⁴⁴

In addition to immune-related effects, high levels of GCs affect neuron structure and survival. Preclinical animal studies have shown reduced hippocampal volume in response to chronic stress-induced elevation of GCs.⁴⁵ GCs also suppress cell proliferation and survival of progenitor cells in the dentate gyrus through the inhibition of cyclic adenosine monophosphate response element binding protein (CREB) and BDNF signaling, resulting in reduced neurogenesis.⁴⁶ Chronic stress induces retraction of apical dendrites in CA3 hippocampal neurons, impairing CA3-CA1 communication.⁴⁷ In addition to effects in the hippocampus, GCs have been shown to impair frontal lobe activity and induce cortical atrophy.^48–51 In consideration of the primary functions of the hippocampus in memory and the frontal cortex in executive function, these findings suggest that increased activity of the HPA axis elevates GC levels which in turn disrupts neuronal survival and maturation, leading to difficulties with learning, trouble concentrating, and impaired problem-solving abilities.⁵²

Reelin Within the Hypothalamic-Pituitary-Adrenal Axis

Reelin is expressed in all the three primary components of the HPA axis: the hypothalamus, pituitary gland, and adrenal glands.^53–55 The presence of reelin and its two primary receptors throughout the HPA axis therefore puts forth a possible role for reelin signaling in HPA axis activity.^55,56

Reelin is Expressed throughout the HPA Axis

Many studies of reelin expression in the hypothalamus have focused on reelin in development, although recent research has begun to explore hypothalamic reelin expression in adulthood. A steady increase in reelin expression in several hypothalamic structures has been observed in developing mice embryos.⁵³ The PVN of the hypothalamus, central to the initiation of the body's response to stressors, is an area of particularly high reelin expression in utero, however, reelin mRNA is also present in the lateral, anterior, and supraoptic divisions of the hypothalamus during this period. Reelin mRNA was detected in the hypothalamic arcuate nucleus (ARC), dorsomedial nucleus (DMH), and PVN of adult mice aged 12–24 weeks, providing support for the emerging concept of reelin expression in the adult hypothalamus.⁵⁴ Similarly, another study of adult rats identified a large number of reelin-IR cells in the PVN in both males and females, providing further support for this idea (see Table 1).⁵⁷ This same study took a deeper look at reelin co-localization in the PVN, determining that seventeen to thirty percent of reelin-IR cells co-localized with parvocellular oxytocin-positive neurons and suggesting that reelin may be expressed adjacent to or within oxytocin-positive neurons in the PVN.⁵⁷ Additional study of reelin in PVN neurons found some co-localization of reelin-IR cells with parvocellular CRH-positive neurons and magnocellular arginine vasopressin (AVP)-positive neurons, although this co-localization was minimal (Figure 1).⁵⁷

Figure 1.

Summary of the regions of the endocrine organs of the HPA axis in which the reelin protein has been identified (A). Summary of the HPA axis, including the hormones implicated in HPA axis function (B). Summary of the PVN functions in which reelin is likely implicated (C). Proposed roles for reelin are denoted by *. Created in BioRender. Thom, S.A. (2025). https://BioRender.com/uy4gmzq.

Table 1.

Summary of the Literature Discussed in the Text Describing the Location of Reelin and its Receptors VLDLR and ApoER2 Throughout the HPA Axis.

Molecule	Organ	Region	Reference
Reelin protein	Hypothalamus	Paraventricular nucleus, arcuate nucleus, lateral nucleus, anterior nucleus, dorsomedial nucleus	Alcántara et al⁵³, Roberts et al⁵⁴, Sánchez-Lafuente et al⁵⁷
	Pituitary gland	Pars intermedia	Smalheiser et al⁵⁵
	Adrenal gland	Adrenal medulla	Smalheiser et al⁵⁵
VLDLR	Hypothalamus	Paraventricular nucleus, arcuate nucleus, suprachiasmatic nucleus, ventromedial nucleus	Roberts et al⁵⁴
	Pituitary gland	Unknown
	Adrenal gland	Zona glomerulosa	Xing et al⁵⁶
ApoER2	Hypothalamus	Paraventricular nucleus, arcuate nucleus, suprachiasmatic nucleus, dorsomedial nucleus, ventromedial nucleus	Roberts et al⁵⁴
	Pituitary gland	Unknown
	Adrenal gland	Unknown

The two primary reelin receptors VLDLR and ApoER2 have also been detected within the adult hypothalamus. As with reelin mRNA, VLDLR mRNA was detected in the PVN and ARC as well as in the ventromedial nucleus (VMH) and suprachiasmatic nucleus (SCN).⁵⁴ ApoER2 mRNA was found to be abundant in all of these regions in addition to the DMH.

Reelin immunoreactivity has also been detected in certain cells of the pituitary pars intermedia that co-express α-melanocyte-stimulating hormone, a neuropeptide with homeostatic and anti-inflammatory functions capable of stimulating the HPA axis (see Table 1).^55,58,59 Reelin immunoreactivity has also been identified in chromaffin cells of the adrenal medulla in female rats (Figure 1).⁵⁵ These cells primarily produce the catecholamines epinephrine and norepinephrine, both of which are necessary for the activation of the sympathetic nervous system in response to acute stress.^60,61 VLDLR mRNA has also been detected in the zona glomerulosa of the adrenal gland, where it may be implicated in the VLDL-stimulated production of aldosterone.⁵⁶ Adrenal production of aldosterone is similarly stimulated by pituitary-derived ACTH (see Table 1).⁶²

Reelin in Healthy HPA Axis Function

The activation of CRH transcription in the PVN requires the phosphorylation of CREB.⁶³ Reelin binding to VLDLR and ApoER2 initiates a signaling cascade that promotes CREB phosphorylation via increased Ca²⁺ influx through NMDARs, and reelin supplementation rapidly induces transient CREB phosphorylation in the hippocampus.^9,64 Although there is no specific evidence for reelin-induced CREB phosphorylation in the PVN (to the author's knowledge), reelin may contribute to the initiation of the stress response through CREB phosphorylation in the PVN in a similar manner to hippocampal processes, as reelin is present in the PVN and cells in the PVN express reelin receptors.^53,54 In line with this, homozygous (reln−/−) or heterozygous (reln+/−) Reeler mice have significantly less circulating ACTH, indicating a potential role for reelin in controlling the production of CRH and ACTH.⁶⁵

It has been proposed that reelin mediates oxytocin expression in the PVN and may dampen HPA axis activity through oxytocin-induced GABAergic transmission. Oxytocin release in the PVN inhibits CRH production through the stimulation of GABAergic interneurons to increase GABA transmission through GABA-A receptors on CRH-producing neurons.^66,67 Oxytocin additionally inhibits the secretion of ACTH from the pituitary and cortisol from the adrenal cortex, providing comprehensive suppression of HPA axis activity.⁶⁸ A significant positive correlation between reelin-IR cell density and oxytocin-IR cell density has been shown within the PVN of both male and female rats.⁵⁷ Chronic stress in the form of three weeks of daily injections of CORT significantly decreases oxytocin-IR cell density in the PVN, and a single intravenous injection of reelin (3 µg) rescues these CORT-induced changes.²³ Furthermore, reelin's function in strengthening and stabilizing synapses by rescuing deficits in LTP, enhancing NMDA receptor activity, and recruiting AMPA receptors may extend to oxytocinergic neurons in the PVN to further support oxytocinergic control over the HPA axis.^13,69 Reelin has been implicated in both the stimulation and inhibition of the HPA axis, suggesting that in healthy conditions, reelin contributes to homeostatic signaling through the HPA axis. Future research should elucidate additional mechanisms through which reelin controls HPA axis signaling, and if reelin is a necessary factor for proper functioning of the HPA axis.

Sex Differences in HPA Axis Function and Sexually Dimorphic Expression of Reelin in the HPA Axis

Women are about twice as likely to be diagnosed with depression than men.⁷⁰ Similarly, the lifetime prevalence of stress-related anxiety disorders including generalized anxiety disorder and post-traumatic stress disorder is thought to be higher in women than in men.⁷¹ It has been proposed that sex differences in HPA axis function contribute to the higher incidence of stress-related disorders in females.⁷² Sex differences in HPA axis function have also been observed in animal models of chronic stress. Compared to males, female rats show a more robust HPA axis-based response to acute restraint stress and exhibit slower resolution of stress-related biochemical changes following a stressor, as evidenced by a delayed return to baseline for ACTH and cortisol/CORT levels.^73–76 Female rats exhibit greater plasma ACTH and CORT levels as well as CRH mRNA expression compared to males following acute stress.⁷⁷ In addition, female rats have been found to have a lower number of hypothalamic CORT cytosolic binding sites and lesser affinity for CORT compared to males.⁷⁸ GR knockout studies have shown differential results depending on region and sex including exaggerated stress responses and depressive-like behavior in males but not females with GR deletion from either the forebrain or the PVN as well as heightened responses in females but not males following GR deletion from GABAergic neurons.^79–81 Interestingly, clinical studies show that women produce stronger responses to stress in low-estrogen phases of the menstrual cycle, suggesting that gonadal hormones may influence the magnitude of a HPA axis response.^82,83 Together, these findings underscore that sex-based distinctions in HPA axis function may help explain the greater vulnerability of women to chronic stress.

Reelin may be implicated in the sex-specific response to stress, as its expression has been shown to vary by sex in basal and chronic stress conditions. The basal density of reelin-IR cells in the hypothalamus was found to be significantly lower in the PVN and medial preoptic area in female rats when compared to males.⁵⁷ Additionally, basal levels of the N-terminal reelin fragment were lower in the hypothalamus of female rats relative to males.⁸⁴ Following long-term exposure to CORT, females did not experience a significant change in reelin-IR cells in the PVN nor did they experience any alterations to N-terminal fragment levels relative to the vehicle-treated controls.^57,84 Similarly, female rats exposed to chronic CORT did not exhibit any significant changes in their levels of DNMT3a, an enzyme that catalyzes DNA methylation of the reelin promoter, compared to control rats.⁸⁴ Researchers also failed to observe any significant difference in MeCP2, a protein implicated in the regulation of gene transcription, between the control and CORT-treated females.⁸⁵ Studies of illnesses in which reelin is downregulated have uncovered hypermethylated reln promoters to which MeCP2 binds in order to suppress transcription. An increase in hypermethylated reln promoters correlates with a decrease in reelin levels.⁸⁶

In contrast with the female rats, male rats exposed to chronic CORT experienced a significant decrease in reelin-IR cells and N-terminal fragment levels in the PVN relative to control males.^57,84 CORT males also expressed significantly higher levels of MeCP2 and less DNMT3a than the male controls.⁸⁴

Altogether, this highlights the sex-specific nature of not only basal reelin expression in the hypothalamus, but also the sexually dimorphic impact of chronic stress on reelin-IR cells, reelin protein fragments, and epigenetic regulators of reelin expression. This suggests that the proposed roles for reelin in regulating HPA axis activity may be more pronounced in males compared to females, despite the greater vulnerability of women to chronic stress-related conditions such as depression. Sex differences in both basal and CORT-influenced reelin expression in the hypothalamus may indicate that reelin is implicated in males’ resilience to stress.

Roles for Reelin in Modulating a Dysfunctional Hypothalamic-Pituitary-Adrenal Axis

Targeting HPA Axis Innervations to Restore HPA Axis Reactivity

The hippocampus and prefrontal cortex (PFC) are heavily involved in regulating HPA axis activity, in part through the inhibition of GC release via PFC and hippocampal output to the bed nucleus of the stria terminalis in the limbic forebrain.^87,88 This output in turn inhibits activity of the PVN to hinder initiation of the body's response to stressors.^87,88 It has been proposed that HPA axis hyperactivity can initiate hippocampal atrophy, which exacerbates HPA axis hyperactivity due to a loss of hippocampal inhibitory feedback over the HPA axis.^89,90 Altered PVN excitability following chronic stress has been reported in various studies.^91,92 Rats exposed to a 3-week chronic unpredictable stress paradigm displayed reduced frequency of miniature inhibitory postsynaptic currents in parvocellular neurons in the PVN, revealing a connection between chronic stress and a reduced number of functional GABAergic synaptic contacts.⁹² In addition, rats undergoing 1 week of chronic variable stress exhibited an increased number of glutamatergic boutons in parvocellular neurons of the PVN.⁹³ Loss of GCs due to adrenalectomy has also been shown to increase the number of GABAergic synapses terminating on PVN CRH-synthesizing neurons.⁹⁴ Decreased levels of GCs associated with adrenalectomy enhances inhibitory signaling of CRH-synthesizing cells, which supports a feedback loop in which GCs regulate HPA axis network excitability (Figure 1). Altogether, these studies highlight inhibitory hippocampal and excitatory GABAergic inputs to the HPA axis as promising targets for the restoration of healthy HPA axis function.

Oxytocin exerts an inhibitory effect on HPA axis activity through projections to GABAergic neurons that inhibit CRH-producing neurons.^66,95 It is released by magnocellular and parvocellular neurons in the PVN, and through projections to the median eminence of the hypothalamus, oxytocin inhibits ACTH-producing cells in the anterior pituitary (Figure 1).⁶⁷ In contrast, AVP, which is synthesized in the PVN, acts synergistically with CRH to stimulate the production of ACTH.^96,97 Parvocellular neurons in the PVN co-expressing AVP and CRH project to the median eminence, where AVP is released and acts upon VP-1b receptors in the anterior pituitary, triggering a signaling pathway culminating in the release of ACTH (Figure 1).⁹⁷ Due to their roles in inhibiting and stimulating CRH and ACTH production, oxytocin, AVP, and CRH-positive neurons present additional targets for reelin in the regulation of HPA axis activity.

Reelin Administration Influences HPA Axis Function

Hypercortisolism is a common occurrence in individuals with depression and is associated with a hyperactive HPA axis producing excess GCs.^98–100 Although studies linking hypercortisolism and reelin in humans are lacking, pre-clinical studies have found that chronically elevated CORT leads to a significant downregulation of reelin-IR cell counts in the hippocampus of adult rats and PVN of male rats and that the administration of reelin rescues these deficits.^22,23,57,69 (Figure 1). Similarly, it is currently understood that reelin administration is capable of rescuing chronic stress-induced decreases to hippocampal LTP, although it is not yet known whether reelin has the same effects on hypothalamic LTP.⁶⁹ Studies of heterozygous (reln+/−) Reeler mice have revealed that mice deficient in reelin experience disruptions to the maturation of GABAergic synaptic transmission in the medial PFC, highlighting a connection between reelin and synaptic plasticity in inhibitory GABAergic neurons.¹⁰¹ In addition, a study of reelin knockout mice identified reduced GABA receptor expression on the plasma membrane of glutamatergic neurons in the neocortex.¹⁰² Since reelin administration restores hippocampal LTP, it may indirectly strengthen hippocampal inhibitory control over hypothalamic activity, highlighting a potential role for reelin in dampening HPA axis hyperactivity in chronic stress and depression.

Research shows that adult hippocampus neurogenesis (AHN) modifies HPA axis activation.^103,104 Chronic unpredictable mild stress reduces AHN and impairs negative feedback regulation, and AHN knockout mice show a heightened HPA axis response to acute stress, characterized by elevated circulating CORT and prolonged recovery to baseline levels of CORT.^103,105,106 Increasing AHN throughout chronic stress via deletion of the pro-apoptotic gene Bax from neural progenitor cells works in an opposing manner, alleviating anhedonia-like behaviors and partially attenuating HPA axis reactivity to acute stress.¹⁰⁷ Reelin administration in a rodent model of chronic stress has been shown to rescue CORT-induced deficits in hippocampal neuron dendritic complexity, maturation, and survival.¹⁰⁸ Reelin's involvement in developing dendritic complexity and neuronal maturation, processes important for neurogenesis, underscores the role of reelin administration in rescuing chronic stress-induced deficits in AHN.¹⁰⁹

As discussed previously, reelin co-localizes with oxytocin-positive parvocellular neurons in the PVN, and further study of reelin has uncovered a positive correlation between reelin-IR and oxytocin-positive cell counts following the administration of a single dose of recombinant reelin.^23,57 Rats receiving chronic CORT have exhibited a decrease in oxytocin-positive cells compared to controls, and administration of reelin following CORT exposure has been shown to partially restore the number of oxytocin-positive cells in the PVN.²³ Although the exact mechanisms through which reelin and oxytocin interact are unknown, this research demonstrates that, in a rodent model of chronic stress, chronically elevated GCs are capable of decreasing oxytocin expression in the PVN and that reelin administration is capable of partially rescuing this decrease. Reelin administration may therefore be beneficial in rescuing inhibition of the HPA axis via interactions with oxytocin-positive neurons. Further research is required, however, to gain an understanding of the functional links between reelin and OXT. Researchers might consider experimenting with PVN OXT-positive neuron readouts in rats exposed to chronic CORT administration, although this study would have to account for sex differences in reelin expression in the PVN following chronic CORT.⁵⁷ Alternately, CNQX might be used to block AMPA receptors in the hypothalamus, as previous research has discovered that CNQX blocks reelin's effects on certain behavioral tests as well as neuronal survival and maturation.¹⁰⁸

Four to seven percent of reelin, CRH, and AVP-positive cells were found to co-localize with one another in a rodent study of chronic stress.⁵⁷ A study of postmortem tissue of depressed patients identified elevated AVP receptor 1a expression in the PVN, while another found elevated plasma AVP and cortisol levels in humans experiencing psychological stress.^110,111 The co-localization of reelin, CRH, and AVP, although minute, highlights a possible relationship between reelin, CRH, and AVP expression, although it is not known whether reelin administration is capable of altering CRH- or AVP-positive cell counts. Further research is required to determine whether reelin can exert a stimulatory effect on HPA axis activity via CRH- and AVP-positive neurons.

Much of the evidence highlighting the possible roles for reelin in influencing dysfunctional HPA axis activity in conditions of chronic stress supports reelin's involvement in inhibitory functions. The presence of some evidence favoring reelin's role in HPA axis stimulation does, however, suggest that both excessive and insufficient reelin levels could play a role in dysregulating HPA axis activity. This idea is supported by research done by our lab which demonstrates that reelin levels are downregulated in a chronic CORT model of depression and that reelin acts in a dose-dependent manner with high and low doses rescuing CORT-induced behavioral and neurochemical changes to a lesser degree than what was determined to be the optimal dose (3 μg).²² Researchers in our lab explored the effects of 0.5, 1, 3, 5, 7, and 9 μg of recombinant reelin in rescuing various behavioral and neurochemical changes associated with chronic CORT administration.²² Dose effects followed a U-shaped profile, and 3 μg was found to rescue CORT-induced changes in the forced swim test and hippocampal reelin-positive cell counts to a greater extent than the other doses tested. 3 μg was also shown to significantly rescue CORT-induced changes in serotonin transporter (SERT) cluster size and GluA1+ cell density.

As previously discussed, preclinical animal studies have explored the effects of reelin administration on various morphological, neurochemical, and behavioral changes associated with a chronic stress phenotype in which hippocampal reelin levels are significantly reduced.^{22,23,69,108,112,113} Results from these studies suggest that increasing endogenous reelin in conditions where reelin is initially downregulated may restore some functions disrupted by chronic stress, such as synaptic plasticity and dendritogenesis, in certain animal models.

Conversely, anti-reelin therapies are undergoing preclinical experimentation as a potential treatment option for certain autoimmune diseases such as multiple sclerosis and rheumatoid arthritis.^114,115 Reelin is currently understood to play a role in inflammation via the modulation of leukocyte-endothelial cell adhesion, and as such it has been theorized that plasma reelin depletion may be effective in ameliorating certain chronic inflammatory illnesses.¹¹⁶ This idea that excessive reelin might be harmful has been supported by animal studies of reelin overexpression in the CNS, which have shown that excess reelin can lead to abnormalities in the organization of adult-generated neurons, synaptic connectivity, and LTP induction.⁸

Altogether, preclinical studies have demonstrated that reelin is less effective in carrying out its functions and is potentially harmful at deficient and excessive levels. The concept of restoring reelin homeostasis rather than administering or depleting reelin may prove valuable in the development of novel reelin-informed therapeutics that regulate dysfunctional HPA axis activity in chronic stress and depression.

Reelin-Informed Considerations for the Development of Novel Therapeutics Targeting the HPA Axis

Known antidepressants such as vortioxetine have been shown to normalize plasma reelin levels in individuals with depression as well as hippocampal reelin levels in rats exposed to chronic stress.^20,117,118 Likewise, ketamine, a NMDA receptor agonist with antidepressant-like effects, has been theorized to act via pathways similar to reelin.⁶⁹ Many of ketamine's antidepressant-like actions are mediated by AMPA receptors.¹¹⁹ Administration of the AMPA receptor antagonist CNQX has been shown to block the effects of reelin administration on a chronic stress phenotype.¹⁰⁸ Similarly, disrupting reelin, ApoER2, and downstream SFKs was shown to block some of the antidepressant-like effects of ketamine.¹²⁰ Altogether this highlights that reelin is potentially more important to existing pathways than is presently understood, and targeting the reelin pathway directly may have important implications for the development of novel therapeutics. Given the involvement of reelin in several cancers and atherosclerosis, however, interventions modifying reelin must be thoroughly tested for safety efficacy.^116,121,122

Another important consideration for the development of therapeutics targeting the reelin pathway is whether reelin can cross the blood brain barrier, as many of reelin's effects in a chronic stress phenotype are observed in the central nervous system. Reelin immunolabeling has been detected in the caveolae of endothelial cells in some small capillaries around layer I of the cortex and the stratum lacunosum moleculare of the hippocampus in adult male rats, suggesting that reelin or reelin peptides may be capable of crossing the BBB.¹²³ Additionally, both intrahippocampal infusion and intravenous injection of exogenous recombinant reelin in adult rats has been shown to increase endogenous reelin in the hippocampus and hypothalamus in a chronic stress phenotype.^22,108 This suggests that reelin administration outside of the central nervous system may lead to effects similar to reelin infusion directly into the brain. Whether the mechanisms through which exogenous reelin influences endogenous reelin levels are direct or indirect is still unknown (to the author's knowledge).

The development of reelin-informed therapeutics must also take into consideration possible biomarkers that can be used to assess therapeutic efficacy. Several blood-based biomarkers can be evaluated in order to assess the effects of reelin administration and the restoration of reelin homeostasis on a dysregulated HPA axis. Cortisol is one hormone that can be assessed. As previously discussed, chronic stress can result in HPA axis hyperactivity and lead to a prolonged elevation of cortisol levels.¹ Cortisol levels can be assessed via plasma, saliva, or urine, but collections must take into account the time in which the sample is collected, as cortisol levels naturally fluctuate throughout the day.^124–126 Similarly, ACTH is another hormone directly involved in HPA axis function that can be measured to evaluate the effects of reelin administration. As with cortisol, HPA axis hyperactivity induced by chronic stress and related disorders results in elevated ACTH levels.¹²⁷ ACTH levels can be assessed via blood test (see Table 2).¹²⁷

Table 2.

Summary of the Proposed Biomarkers for the Assessment of HPA Axis Function Following the Restoration of Reelin Homeostasis.

Biomarker	Rationale	Reference
Cortisol	Chronic stress can result in HPA axis hyperactivity, which leads to a prolonged elevation of cortisol levels. Cortisol levels can be assessed via plasma, saliva, or urine	Sheng et al¹, Fang et al¹²⁴, Raff et al¹²⁵, Flack et al¹²⁶
ACTH	HPA axis hyperactivity induced by chronic stress results in elevated levels of ACTH. ACTH levels can be assessed via blood test	Kunugi et al¹²⁷
FKBP5	High levels of FKBP5 are associated with chronic stress and depression. FKBP5 regulates GR sensitivity by reducing their binding affinity for cortisol and impairs the negative feedback loop, making the HPA axis more prone to hyperactivity. FKBP5 mRNA expression can be assessed via blood test	Ising et al¹²⁸, Binder¹²⁹
BDNF	High levels of cortisol have been linked to reduced plasma BDNF levels in an animal model and have been rescued by antidepressant treatment in depressed patients. BDNF levels can be assessed via blood test	Smith et al¹³⁰, Murakami et al¹³¹, Brunoni et al¹³²
Pro-Inflammatory Cytokines	Chronic stress has been shown to diminish the ability of cortisol to suppress the immune system, resulting in a prolonged elevation of pro-inflammatory cytokines such as interleukin-6 and interleukin-1. A blood sample can be taken to assess pro-inflammatory cytokine levels	Sorrells et al¹³³, Howren et al¹³⁴, Yoshimura et al¹³⁵

High levels of the protein FKBP5 are associated with HPA axis hyperactivity and have been observed in individuals with depression.¹²⁸ FKBP5 regulates GR sensitivity by reducing their binding affinity for cortisol and at high levels can impair the negative feedback loop regulating the HPA axis, making it more prone to hyperactivity.¹²⁹ Animal studies have demonstrated that high levels of CORT resulting from chronic stress are linked to reduced neuronal BDNF levels.^130,131 Studies of individuals with depression have also observed an increase in plasma BDNF following antidepressant treatment.¹³² A blood test can be used to quantify both FKBP5 mRNA expression and BDNF levels in individuals experiencing chronic stress and depression-related HPA axis dysfunction (see Table 2).^128,132

Prolonged elevation of cortisol levels as a result of HPA axis hyperactivity can also suppress the immune system.¹³³ This results in elevated levels of pro-inflammatory cytokines such as interleukin-6 and interleukin-1, as have been observed in depressed patients.^133–135 A blood sample can be taken to assess pro-inflammatory cytokine levels in patients experiencing HPA axis hyperactivity as a result of depression and other stress-related disorders (see Table 2).¹³⁵

Conclusions

In summary, this review discusses the extensive presence of reelin and its receptors throughout the HPA axis, particularly within the various nuclei of the hypothalamus. This review proposes several roles for reelin administration in various aspects of HPA axis inhibition and stimulation. It ultimately highlights an important function for reelin homeostasis in potentially restoring disrupted HPA axis activity in chronic stress conditions. Altogether, these conclusions call attention to future avenues for research uncovering the mechanisms through which reelin may act within the HPA axis. Further research will expand current understanding of the roles of reelin in chronic stress, providing valuable insight into the neurobiology of depression.

Footnotes

Abbreviations

ORCID iDs

Sophie A. Thom

Ciara S. Halvorson

Brady S. Reive

Carla L. Sànchez-Lafuente

Lisa E. Kalynchuk

Hector J. Caruncho

Ethical Considerations

Not applicable.

Consent to Participate

Not applicable.

Consent for Pblication

Not applicable.

Author Contributions

H.J.C. and L.E.K. conceptualized and reviewed the manuscript. S.A.T. reviewed the literature, made the figures, and wrote the manuscript. C.S.H. edited and wrote sections of the manuscript. B.S.R. and C.L.S. edited the manuscript. All authors have read and agreed to the published version of the manuscript.

Funding

The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the NSERC DG to HJC and LEK, and the CIHR PG and CRC to HJC.

Declaration of Conflicting Interests

The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

References

Sheng

Bales

Myers

, et al. The hypothalamic-pituitary-adrenal axis: Development, programming actions of hormones, and maternal-fetal interactions. Front Behav Neurosci. 2021;14:601939. doi:10.3389/fnbeh.2020.601939

Zunszain

Anacker

Cattaneo

, et al. Glucocorticoids, cytokines and brain abnormalities in depression. Prog Neuropsychopharmacol Biol Psychiatry. 2011;35(3):722–729. doi:10.1016/j.pnpbp.2010.04.011

Falconer

. Two new mutants, ‘trembler’ and ‘reeler’, with neurological actions in the house mouse (Mus musculus L.). J Genet. 1951;50(2):192–205. doi:10.1007/BF02996215

D’Arcangelo

Miao

Chen

, et al. A protein related to extracellular matrix proteins deleted in the mouse mutant reeler. Nature. 1995;374(6524):719–723. doi:10.1038/374719a0

Goffinet

. Events governing organization of postmigratory neurons: Studies on brain development in normal and reeler mice. Brain Res Rev. 1984;7(3):261–296. doi:10.1016/0165-0173(84)90013-4

Tissir

Goffinet

. Reelin and brain development. Nat Rev Neurosci. 2003;4(6):496–505. doi:10.1038/nrn1113

Yip

Nakajima

, et al. Reelin controls position of autonomic neurons in the spinal cord. Proc Natl Acad Sci USA. 2000;97(15):8612–8616. doi:10.1073/pnas.150040497

Pujadas

Gruart

Bosch

, et al. Reelin regulates postnatal neurogenesis and enhances spine hypertrophy and long-term potentiation. J Neurosci Off J Soc Neurosci. 2010;30(13):4636–4649. doi:10.1523/JNEUROSCI.5284-09.2010

Rogers

Rusiana

Trotter

, et al. Reelin supplementation enhances cognitive ability, synaptic plasticity, and dendritic spine density. Learn Mem. 2011;18(9):558–564. doi:10.1101/lm.2153511

10.

Jossin

. Reelin functions, mechanisms of action and signaling pathways during brain development and maturation. Biomolecules. 2020;10(6):964. doi:10.3390/biom10060964

11.

Strasser

Fasching

Hauser

, et al. Receptor clustering is involved in reelin signaling. Mol Cell Biol. 2004;24(3):1378–1386. doi:10.1128/MCB.24.3.1378-1386.2004

12.

Durakoglugil

Chen

White

, et al. Reelin signaling antagonizes β-amyloid at the synapse. Proc Natl Acad Sci. 2009;106(37):15938–15943. doi:10.1073/pnas.0908176106

13.

Qiu

Zhao

Korwek

, et al. Differential reelin-induced enhancement of NMDA and AMPA receptor activity in the adult hippocampus. J Neurosci. 2006;26(50):12943–12955. doi:10.1523/JNEUROSCI.2561-06.2006

14.

Bal

Leitz

Reese

, et al. Reelin mobilizes a VAMP7-dependent synaptic vesicle pool and selectively augments spontaneous neurotransmission. Neuron. 2013;80(4):934–946. doi:10.1016/j.neuron.2013.08.024

15.

Beffert

Morfini

Bock

, et al. Reelin-mediated signaling locally regulates protein kinase B/akt and glycogen synthase kinase 3β. J Biol Chem. 2002;277(51):49958–49964. doi:10.1074/jbc.M209205200

16.

Teixeira

Kron

Masachs

, et al. Cell-autonomous inactivation of the reelin pathway impairs adult neurogenesis in the hippocampus. J Neurosci. 2012;32(35):12051–12065. doi:10.1523/JNEUROSCI.1857-12.2012

17.

Fatemi

Earle

McMenomy

. Reduction in reelin immunoreactivity in hippocampus of subjects with schizophrenia, bipolar disorder and major depression. Mol Psychiatry. 2000;5(6):654–663. doi:10.1038/sj.mp.4000783

18.

Folsom

Fatemi

. The involvement of reelin in neurodevelopmental disorders. Neuropharmacology. 2013;68:122–135. doi:10.1016/j.neuropharm.2012.08.015

19.

Ishii

Kubo

Nakajima

. Reelin and neuropsychiatric disorders. Front Cell Neurosci. 2016;10:229. doi:10.3389/fncel.2016.00229

20.

Jin

Zhang

Jiang

, et al. The role of reelin in the pathological mechanism of depression from clinical to rodents. Psychiatry Res. 2022;317:114838. doi:10.1016/j.psychres.2022.114838

21.

Joly-Amado

Kulkarni

Nash

. Reelin signaling in neurodevelopmental disorders and neurodegenerative diseases. Brain Sci. 2023;13(10):1479. doi:10.3390/brainsci13101479

22.

Allen

Romay-Tallon

Mitchell

, et al. Reelin has antidepressant-like effects after repeated or singular peripheral injections. Neuropharmacology. 2022;211:109043. doi:10.1016/j.neuropharm.2022.109043

23.

Sánchez-Lafuente

Johnston

Reive

, et al. A single intravenous reelin injection restores corticosterone-induced neurochemical and behavioral alterations in dams during the post-partum period. Front Mol Neurosci. 2024;17:1442332. doi:10.3389/fnmol.2024.1442332

24.

Zhang

Qin

Zhao

. Early repeated maternal separation induces alterations of hippocampus reelin expression in rats. J Biosci. 2013;38(1):27–33. doi:10.1007/s12038-012-9286-3

25.

Lossi

Castagna

Granato

, et al.

The reeler mouse: A translational model of human neurological conditions, or simply a good tool for better understanding neurodevelopment?

J Clin Med. 2019;8(12):2088. doi:10.3390/jcm8122088

26.

Busillo

Cidlowski

. The five Rs of glucocorticoid action during inflammation: Ready, reinforce, repress, resolve, and restore. Trends Endocrinol Metab. 2013;24(3):109–119. doi:10.1016/j.tem.2012.11.005

27.

Dabbah-Assadi

Handel

Shamir

. What we know about the role of corticosteroids in psychiatric disorders; evidence from animal and clinical studies. J Psychiatr Res. 2022;155:363–370. doi:10.1016/j.jpsychires.2022.09.032

28.

Prado

Crowe

. Corticosteroids and cognition: A meta-analysis. Neuropsychol Rev. 2019;29(3):288–312. doi:10.1007/s11065-019-09405-8

29.

Warrington

Bostwick

. Psychiatric adverse effects of corticosteroids. Mayo Clin Proc. 2006;81(10):1361–1367. doi:10.4065/81.10.1361

30.

Spencer

Deak

. A users guide to HPA axis research. Physiol Behav. 2017;178:43–65. doi:10.1016/j.physbeh.2016.11.014

31.

Harno

Gali Ramamoorthy

Coll

, et al. POMC: The physiological power of hormone processing. Physiol Rev. 2018;98(4):2381–2430. doi:10.1152/physrev.00024.2017

32.

Bekhbat

Rowson

Neigh

. Checks and balances: The glucocorticoid receptor and NFĸB in good times and bad. Front Neuroendocrinol. 2017;46:15–31. doi:10.1016/j.yfrne.2017.05.001

33.

Nicolaides

Chrousos

Kino

, et al. Glucocorticoid receptor. In: Feingold

Ahmed

Anawalt

, eds. Endotext [Internet]. MDText.com, Inc.; 2000:para. 1.

34.

Vellapandian

. Hypothalamic-pituitary-adrenal (HPA) axis: Unveiling the potential mechanisms involved in stress-induced Alzheimer’s disease and depression. Cureus. 2024;16(8):e67595.

35.

Zhang

Hong

, et al. Hyperactivity of hypothalamic-pituitary-adrenal axis due to dysfunction of the hypothalamic glucocorticoid receptor in sigma-1 receptor knockout mice. Front Mol Neurosci. 2017;10:287. doi:10.3389/fnmol.2017.00287

36.

Boyle

Brewer

Funatsu

, et al. Acquired deficit of forebrain glucocorticoid receptor produces depression-like changes in adrenal axis regulation and behavior. Proc Natl Acad Sci. 2005;102(2):473–478. doi:10.1073/pnas.0406458102

37.

Jia

Zhang

. Effects of glucocorticoids on leukocytes: Genomic and non-genomic mechanisms. World J Clin Cases. 2022;10(21):7187–7194. doi:10.12998/wjcc.v10.i21.7187

38.

Cohen

Janicki-Deverts

Doyle

, et al. Chronic stress, glucocorticoid receptor resistance, inflammation, and disease risk. Proc Natl Acad Sci. 2012;109(16):5995–5999. doi:10.1073/pnas.1118355109

39.

Walsh

Bovbjerg

Marsland

. Glucocorticoid resistance and β2-adrenergic receptor signaling pathways promote peripheral pro-inflammatory conditions associated with chronic psychological stress: A systematic review across species. Neurosci Biobehav Rev. 2021;128:117–135. doi:10.1016/j.neubiorev.2021.06.013

40.

Felger

Lotrich

. Inflammatory cytokines in depression: Neurobiological mechanisms and therapeutic implications. Neuroscience. 2013;246:199–229. doi:10.1016/j.neuroscience.2013.04.060

41.

Maes

Leonard

Myint

, et al. The new ‘5-HT’ hypothesis of depression: Cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression. Prog Neuropsychopharmacol Biol Psychiatry. 2011;35(3):702–721.

42.

Calabrese

Rossetti

Racagni

, et al. Brain-derived neurotrophic factor: A bridge between inflammation and neuroplasticity. Front Cell Neurosci. 2014;8:430.

43.

Carvalho

Caldeira

Santos

, et al. Role of the brain-derived neurotrophic factor at glutamatergic synapses. Br J Pharmacol. 2008;153(S1):S310–S324.

44.

Duman

Aghajanian

Sanacora

, et al. Synaptic plasticity and depression: New insights from stress and rapid-acting antidepressants. Nat Med. 2016;22(3):238–249.

45.

Tata

Anderson

. The effects of chronic glucocorticoid exposure on dendritic length, synapse numbers and glial volume in animal models: Implications for hippocampal volume reductions in depression. Physiol Behav. 2010;99(2):186–193.

46.

McEwen

Nasca

Gray

. Stress effects on neuronal structure: Hippocampus, amygdala, and prefrontal cortex. Neuropsychopharmacology. 2016 Jan;41(1):3–23.

47.

Sun

Zhong

Cao

, et al. Repeated restraint stress led to cognitive dysfunction by NMDA receptor-mediated hippocampal CA3 dendritic spine impairments in juvenile Sprague-Dawley rats. Front Mol Neurosci. 2020;13:552787.

48.

Carrion

Weems

Richert

, et al. Decreased prefrontal cortical volume associated with increased bedtime cortisol in traumatized youth. Biol Psychiatry. 2010;68(5):491–493.

49.

Goldwater

Pavlides

Hunter

, et al. Structural and functional alterations to rat medial prefrontal cortex following chronic restraint stress and recovery. Neuroscience. 2009;164(2):798–808.

50.

Lebedeva

Sundström

Lindgren

, et al. Longitudinal relationships among depressive symptoms, cortisol, and brain atrophy in the neocortex and the hippocampus. Acta Psychiatr Scand. 2018;137(6):491–502.

51.

Wheelock

Harnett

Wood

, et al. Prefrontal cortex activity is associated with biobehavioral components of the stress response. Front Hum Neurosci. 2016;10:583.

52.

Lam

Kennedy

McIntyre

, et al. Cognitive dysfunction in major depressive disorder: Effects on psychosocial functioning and implications for treatment. Can J Psychiatry. 2014;59(12):649–654.

53.

Alcántara

Ruiz

D’Arcangelo

, et al. Regional and cellular patterns of reelin mRNA expression in the forebrain of the developing and adult mouse. J Neurosci. 1998;18(19):7779–7799.

54.

Roberts

Bennett

, et al. Reelin is modulated by diet-induced obesity and has direct actions on arcuate proopiomelanocortin neurons. Mol Metab. 2019;26:18–29.

55.

Smalheiser

Costa

Guidotti

, et al. Expression of reelin in adult mammalian blood, liver, pituitary pars intermedia, and adrenal chromaffin cells. Proc Natl Acad Sci. 2000;97(3):1281–1286.

56.

Xing

Rainey

Apolzan

, et al. Adrenal cell aldosterone production is stimulated by very-low-density lipoprotein (VLDL). Endocrinology. 2012;153(2):721–731.

57.

Sánchez-Lafuente

Romay-Tallon

Allen

, et al. Sex differences in basal reelin levels in the paraventricular hypothalamus and in response to chronic stress induced by repeated corticosterone in rats. Horm Behav. 2022;146:105267.

58.

Xiao

Xia-Zhang

Vulliémoz

, et al. Agouti-related protein stimulates the hypothalamic-pituitary-adrenal (HPA) axis and enhances the HPA response to interleukin-1 in the primate. Endocrinology. 2003;144(5):1736–1741.

59.

Dhillo

Small

Seal

, et al. The hypothalamic melanocortin system stimulates the hypothalamo-pituitary-adrenal axis in vitro and in vivo in male rats. Neuroendocrinology. 2002;75(4):209–216.

60.

Carbone

Borges

Eiden

, et al. Chromaffin cells of the adrenal medulla: Physiology, pharmacology, and disease. Compr Physiol. 2019;9(4):1443–1502.

61.

Herman

Figueiredo

Mueller

, et al. Neurochemical systems regulating the hypothalamo-pituitary-adrenocortical axis. In: Lajtha

Blaustein

, eds. Handbook of Neurochemistry and Molecular Neurobiology. 3rd ed. Springer; 2007:513–569.

62.

Bollag

. Regulation of aldosterone synthesis and secretion. Compr Physiol. 2014;4(3):1017–1055.

63.

Liu

Kamitakahara

Kim

, et al. Cyclic adenosine 3′,5′-monophosphate responsive element binding protein phosphorylation is required but not sufficient for activation of corticotropin-releasing hormone transcription. Endocrinology. 2008;149(7):3512–3520.

64.

Chen

Beffert

Ertunc

, et al. Reelin modulates NMDA receptor activity in cortical neurons. J Neurosci. 2005;25(36):8209–8216.

65.

Lombardero

Kovacs

Horvath

, et al. Hormonal and morphological study of the pituitaries in reeler mice. Int J Exp Pathol. 2007;88(3):165–173.

66.

Bülbül

Babygirija

Cerjak

, et al. Hypothalamic oxytocin attenuates CRF expression via GABAA receptors in rats. Brain Res. 2011;1387:39–45.

67.

Uvnäs-Moberg

Gross

Calleja-Agius

, et al. The yin and yang of the oxytocin and stress systems: Opposites, yet interdependent and intertwined determinants of lifelong health trajectories. Front Endocrinol. 2024;15:1272270.

68.

Handlin

Jonas

Petersson

, et al. Effects of sucking and skin-to-skin contact on maternal ACTH and cortisol levels during the second day postpartum—influence of epidural analgesia and oxytocin in the perinatal period. Breastfeed Med. 2009;4(4):207–220.

69.

Johnston

Allen

Shkolnikov

, et al. Reelin rescues behavioral, electrophysiological, and molecular metrics of a chronic stress phenotype in a similar manner to ketamine. eNeuro. 2023;10(8):1–13.

70.

Baxter

Scott

Ferrari

, et al. Challenging the myth of an “epidemic” of common mental disorders: Trends in the global prevalence of anxiety and depression between 1990 and 2010. Depress Anxiety. 2014;31(6):506–516.

71.

McLean

Asnaani

Litz

, et al. Gender differences in anxiety disorders: Prevalence, course of illness, comorbidity and burden of illness. J Psychiatr Res. 2011;45(8):1027–1035.

72.

Brydges

Best

Thomas

. Female HPA axis displays heightened sensitivity to pre-pubertal stress. Stress. 2020;23(2):190–200.

73.

Babb

Masini

Day

HEW

, et al. Sex differences in activated corticotropin-releasing factor neurons within stress-related neurocircuitry and hypothalamic–pituitary–adrenocortical axis hormones following restraint in rats. Neuroscience. 2013;234:40–52.

74.

Heck

Handa

. Sex differences in the hypothalamic–pituitary–adrenal axis’ response to stress: An important role for gonadal hormones. Neuropsychopharmacology. 2019;44(1):45–58.

75.

Sharma

Aoun

Wigham

, et al. Gender determines ACTH recovery from hypercortisolemia in healthy older humans. Metabolism. 2013;62(12):1819–1829.

76.

Stroud

Papandonatos

Williamson

, et al. Sex differences in cortisol response to corticotropin releasing hormone challenge over puberty: Pittsburgh Pediatric Neurobehavioral Studies. Psychoneuroendocrinology. 2011;36(8):1226–1238.

77.

Iwasaki-Sekino

Mano-Otagiri

Ohata

, et al. Gender differences in corticotropin and corticosterone secretion and corticotropin-releasing factor mRNA expression in the paraventricular nucleus of the hypothalamus and the central nucleus of the amygdala in response to footshock stress or psychological stress in rats. Psychoneuroendocrinology. 2009;34(2):226–237.

78.

Turner

Weaver

. Sexual dimorphism of glucocorticoid binding in rat brain. Brain Res. 1985;343(1):16–23.

79.

Scheimann

Mahbod

Morano

, et al. Deletion of glucocorticoid receptors in forebrain GABAergic neurons alters acute stress responding and passive avoidance behavior in female mice. Front Behav Neurosci. 2018;12:325.

80.

Solomon

Furay

Jones

, et al. Deletion of forebrain glucocorticoid receptors impairs neuroendocrine stress responses and induces depression-like behavior in males but not females. Neuroscience. 2012;203:135–143.

81.

Solomon

Loftspring

de Kloet

, et al. Neuroendocrine function after hypothalamic depletion of glucocorticoid receptors in male and female mice. Endocrinology. 2015;156(8):2843–2853.

82.

Albert

Pruessner

Newhouse

. Estradiol levels modulate brain activity and negative responses to psychosocial stress across the menstrual cycle. Psychoneuroendocrinology. 2015;59:14–24.

83.

Jain

Chauhan

Singh

, et al. Correlation of perceived stress with monthly cyclical changes in the female body. J Fam Med Prim Care. 2023;12(11):2927.

84.

Sánchez-Lafuente

Martinez-Verbo

Johnston

, et al. Chronic corticosterone exposure in rats induces sex-specific alterations in hypothalamic reelin fragments, MeCP2, and DNMT3a protein levels. Neurosci Lett. 2024;830:137770.

85.

Karaca K

Brito

DVC

Oliveira

AMM

. MeCP2: A critical regulator of chromatin in neurodevelopment and adult brain function. Int J Mol Sci. 2019;20(18):4577.

86.

Sánchez-Lafuente

Kalynchuk

Caruncho

, et al. The role of MeCP2 in regulating synaptic plasticity in the context of stress and depression. Cells. 2022;11(4):748.

87.

Choi

Furay

Evanson

, et al. Bed nucleus of the stria terminalis subregions differentially regulate hypothalamic–pituitary–adrenal axis activity: Implications for the integration of limbic inputs. J Neurosci. 2007;27(8):2025–2034.

88.

Cole

Montgomery

Bale

, et al. What the hippocampus tells the HPA axis: Hippocampal output attenuates acute stress responses via disynaptic inhibition of CRF+ PVN neurons. Neurobiol Stress. 2022;20:100473.

89.

Mbiydzenyuy

Qulu

. Stress, hypothalamic-pituitary-adrenal axis, hypothalamic-pituitary-gonadal axis, and aggression. Metab Brain Dis. 2024;39(8):1613–1636.

90.

Resmini

Santos

Gómez-Anson

, et al. Verbal and visual memory performance and hippocampal volumes, measured by 3-tesla magnetic resonance imaging, in patients with Cushing’s syndrome. J Clin Endocrinol Metab. 2012;97(2):663–671.

91.

Joëls

Karst

Alfarez

, et al. Effects of chronic stress on structure and cell function in rat hippocampus and hypothalamus. Stress. 2004;7(4):221–231.

92.

Verkuyl

Hemby

Joëls

. Chronic stress attenuates GABAergic inhibition and alters gene expression of parvocellular neurons in rat hypothalamus. Eur J Neurosci. 2004;20(6):1665–1673.

93.

Flak

Ostrander

Tasker

, et al. Chronic stress-induced neurotransmitter plasticity in the PVN. J Comp Neurol. 2009;517(2):156–165.

94.

Miklós

Kovács

. GABAergic innervation of corticotropin-releasing hormone (CRH)-secreting parvocellular neurons and its plasticity as demonstrated by quantitative immunoelectron microscopy. Neuroscience. 2002;113(3):581–592.

95.

Neumann

Wigger

Torner

, et al. Brain oxytocin inhibits basal and stress-induced activity of the hypothalamo-pituitary-adrenal axis in male and female rats: Partial action within the paraventricular nucleus. J Neuroendocrinol. 2000;12(3):235–243.

96.

Cuzzo

Padala

Lappin

. Physiology, vasopressin. In: StatPearls [Internet]. FL: StatPearls Publishing; 2025:para. 2. http://www.ncbi.nlm.nih.gov/books/NBK526069/

97.

Lolait

Stewart

Jessop

, et al. The hypothalamic-pituitary-adrenal axis response to stress in mice lacking functional vasopressin V1b receptors. Endocrinology. 2007;148(2):849–856.

98.

Reiss

Hemphill

Gordon

, et al. Regulation of urinary steroid excretion. 2. Spontaneous changes in the pattern of daily excretion in mental patients. Biochem J. 1949;45(5):574–578.

99.

Schlechte

Sherman

Pfohl

. A comparison of adrenal cortical function in patients with depressive illness and Cushing’s disease. Horm Res. 2008;23(1):1–8.

100.

van Haalen

van Dijk

EHC

Dekkers

, et al. Cushing’s syndrome and hypothalamic–pituitary–adrenal axis hyperactivity in chronic central serous chorioretinopathy. Front Endocrinol. 2018;9(39):1–7.

101.

Bouamrane

Scheyer

Lassalle

, et al. Reelin-haploinsufficiency disrupts the developmental trajectory of the E/I balance in the prefrontal cortex. Front Cell Neurosci. 2017;10:308.

102.

Hamad

MIK

Jbara

Rabaya

, et al. Reelin signaling modulates GABAB receptor function in the neocortex. J Neurochem. 2021;156(5):589–603.

103.

Surget

Tanti

Leonardo

, et al. Antidepressants recruit new neurons to improve stress response regulation. Mol Psychiatry. 2011;16(12):1177–1188.

104.

Surget

Belzung

. Adult hippocampal neurogenesis shapes adaptation and improves stress response: A mechanistic and integrative perspective. Mol Psychiatry. 2022;27(1):403–421.

105.

Schloesser

Manji

Martinowich

. Suppression of adult neurogenesis leads to an increased hypothalamo-pituitary-adrenal axis response. NeuroReport. 2009;20(6):553.

106.

Snyder

Soumier

Brewer

, et al. Adult hippocampal neurogenesis buffers stress responses and depressive behaviour. Nature. 2011;476(7361):458–461.

107.

Eliwa

Brizard

Guisquet

AML

, et al. Adult neurogenesis augmentation attenuates anhedonia and HPA axis dysregulation in a mouse model of chronic stress and depression. Psychoneuroendocrinology. 2021;124:105097.

108.

Brymer

Johnston

Botterill

, et al. Fast-acting antidepressant-like effects of reelin evaluated in the repeated-corticosterone chronic stress paradigm. Neuropsychopharmacology. 2020;45(10):1707–1716.

109.

Yau

. Adult neurogenesis and dendritic remodeling in hippocampal plasticity: Which one is more important? Cell Transplant. 2014;23(4–5):471–479.

110.

Wang

Kamphuis

Huitinga

, et al. Gene expression analysis in the human hypothalamus in depression by laser microdissection and real-time PCR: The presence of multiple receptor imbalances. Mol Psychiatry. 2008;13(8):786–799.

111.

Bao

Jiang

Sun

, et al. The influence of psychological stress on arginine vasopressin concentration in the human plasma and cerebrospinal fluid. Neuropeptides. 2014;48(6):361–369.

112.

Scheil

KKA

Sánchez-Lafuente

Reive

, et al. Time-dependent antidepressant-like effects of reelin and ketamine in the repeated-corticosterone model of chronic stress. Prog Neuro-Psychopharmacol Biol Psychiatry. 2024;132:110998.

113.

Reive

Johnston

Sánchez-Lafuente

, et al. Intravenous reelin rescues despair-like behavior, reelin cells in the dentate sub-granular zone, and spleen atrophy in the cyclic corticosterone model of recurring depressive episodes. Front Pharmacol. 2024;15:1368620.

114.

Calvier

Wasser

Solow

, et al. Genetic or therapeutic disruption of the reelin/Apoer2 signaling pathway improves inflammatory arthritis outcomes. Proc Natl Acad Sci. 2025;122(11):e2418642122.

115.

Calvier

Demuth

Manouchehri

, et al. Reelin depletion protects against autoimmune encephalomyelitis by decreasing vascular adhesion of leukocytes. Sci Transl Med. 2020;12(556):eaay7675.

116.

Ding

Huang

Xian

, et al. Loss of reelin protects against atherosclerosis by reducing leukocyte–endothelial cell adhesion and lesion macrophage accumulation. Sci Signal. 2016;9(419):ra29.

117.

Brymer

Fenton

Kalynchuk

, et al. Peripheral etanercept administration normalizes behavior, hippocampal neurogenesis, and hippocampal reelin and GABAA receptor expression in a preclinical model of depression. Front Pharmacol. 2018;9:121.

118.

Fenton

Fournier

Lussier

, et al. Imipramine protects against the deleterious effects of chronic corticosterone on depression-like behavior, hippocampal reelin expression, and neuronal maturation. Prog Neuro-Psychopharmacol Biol Psychiatry. 2015;60:52–59.

119.

Maeng

Zarate

, et al. Cellular mechanisms underlying the antidepressant effects of ketamine: Role of α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors. Biol Psychiatry. 2008;63(4):349–352.

120.

Kim

Herz

Kavalali

, et al. A key requirement for synaptic reelin signaling in ketamine-mediated behavioral and synaptic action. Proc Natl Acad Sci. 2021;118(20):e2103079118.

121.

Qin

Lin

Cao

, et al. Extracellular matrix protein reelin promotes myeloma progression by facilitating tumor cell proliferation and glycolysis. Sci Rep. 2017;7(1):45305.

122.

Stein

Cosimo

, et al. Loss of reelin expression in breast cancer is epigenetically controlled and associated with poor prognosis. Am J Pathol. 2010;177(5):2323–2333.

123.

Perez-Costas

Fenton

Caruncho

. Reelin expression in brain endothelial cells: An electron microscopy study. BMC Neurosci. 2015;16:16.

124.

Fang

Tricou

Robertson

, et al. Plasma ACTH and cortisol levels in depressed patients: Relation to dexamethasone suppression test. Life Sci. 1981;29(9):931–938.

125.

Raff

Findling

. Late-night salivary cortisol as a screening test for Cushing’s Syndrome. J Clin Endocrinol Metab. 1998;83(8):2681–2686.

126.

Flack

Oldfield

Cutler

, et al. Urine free cortisol in the high-dose dexamethasone suppression test for the differential diagnosis of the Cushing Syndrome. Ann Intern Med. 1992;116(3):211–217.

127.

Kunugi

Ida

Owashi

, et al. Assessment of the dexamethasone/CRH test as a state-dependent marker for hypothalamic-pituitary-adrenal (HPA) axis abnormalities in major depressive episode: A multicenter study. Neuropsychopharmacol. 2006;31(1):212–220.

128.

Ising

Maccarrone

Brückl

, et al. FKBP5 Gene expression predicts antidepressant treatment outcome in depression. Int J Mol Sci. 2019;20(3):485.

129.

Binder

. The role of FKBP5, a co-chaperone of the glucocorticoid receptor in the pathogenesis and therapy of affective and anxiety disorders. Psychoneuroendocrinology. 2009;34(Suppl. 1):S186–S195.

130.

Smith

Makino

Kvetnansky

, et al. Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. J Neurosci. 1995;15(3):1768–1777.

131.

Murakami

Imbe

Morikawa

, et al. Chronic stress, as well as acute stress, reduces BDNF mRNA expression in the rat hippocampus but less robustly. Neurosci Res. 2005;53(2):129–139.

132.

Brunoni

Lopes

Fregni

. A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: Implications for the role of neuroplasticity in depression. Int J Neuropsychopharmacol. 2008;11(8):1169–1180.

133.

Sorrells

Caso

Munhoz

, et al. The stressed CNS: When glucocorticoids aggravate inflammation. Neuron. 2009;64(1):33–39.

134.

Howren

Lamkin

Suls

. Associations of depression with C-reactive protein, IL-1, and IL-6: A meta-analysis. Biopsychosoc Sci Med. 2009;71(2):171.

135.

Yoshimura

Kishi

Iwata

. Plasma levels of IL-6 in patients with untreated major depressive disorder: Comparison with catecholamine metabolites. Neuropsychiatr Dis Treat. 2019;15:2655–2661.

Reelin,the HPA Axis,and Chronic Stress: Implications for the Neurobiology of Depression

Abstract

Keywords

Introduction

Neurobiological Progressions of Chronic Stress and Hypothalamic-Pituitary-Adrenal Axis Involvement

Reelin Within the Hypothalamic-Pituitary-Adrenal Axis

Reelin is Expressed throughout the HPA Axis

Reelin in Healthy HPA Axis Function

Sex Differences in HPA Axis Function and Sexually Dimorphic Expression of Reelin in the HPA Axis

Roles for Reelin in Modulating a Dysfunctional Hypothalamic-Pituitary-Adrenal Axis

Targeting HPA Axis Innervations to Restore HPA Axis Reactivity

Reelin Administration Influences HPA Axis Function

Reelin-Informed Considerations for the Development of Novel Therapeutics Targeting the HPA Axis

Conclusions

Footnotes

Abbreviations

ORCID iDs

Ethical Considerations

Consent to Participate

Consent for Pblication

Author Contributions

Funding

Declaration of Conflicting Interests

References